For example, by mitigating the activity of the PI3K-AKT-eNOS Ras pathway, or the NF-κB pathway, NOS inhibition has the potential to affect many components of tumor maintenance and growth [2], [6], [10]. The gene discussed is AKT1; the disease is neoplasm.